[Symposium] On behalf of the Organizing Committee, we are excited to announce MedChem by Design Europe 2024. This is a 1-day symposium focusing on benefits of computer-aided ligand and structure-based drug design techniques for medicinal chemists (see below). The event is scheduled to take place on October 9, 2024, at the Hyperion Hotel, in Basel, Switzerland.
The morning sessions will feature hands-on workshops, followed by scientific presentations in the afternoon. For more information, please visit https://bit.ly/3WM1oZB
> CONFIRMED SPEAKERS TO DATE<
“Presentation Title to Be Announced”
Bernd Kuhn, Distinguished Scientist, CADD, F. Hoffmann-La Roche Ltd.
“Nonclassical Zwitterions as a Design Principle to Reduce Lipophilicity without Impacting Permeability”
Henrik Möbitz, Director (CADD, Global Discovery Chemistry), Novartis
“Presentation Title to Be Announced”
Vladas Oleinikovas, Director of Computational Chemistry, VantAI
“Presentation Title to Be Announced”
Anna Vulpetti, Associate Director, CADD / Global Chemistry, Novartis
> PRELIMINARY AGENDA | October 09, 2024 <
MORNING SESSIONS - Workshops
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
08:15 Morning Coffee / Registration (check-in/badge pick-up)
09:00 Small Molecule Docking (Protein-Ligand Interaction Analysis, Protein-Ligand Docking, Pharmacophore Modeling, High-throughput Docking, Template-Based Docking...)
10:30 Morning Break
11:00 Fragment-based Design: Scaffold Hopping, Fragment Growing and Bioisosteric Replacements (Scaffold Replacement, Ligand Growing, Bioisosteric Transformations, Pharmacophore Modeling...)
12:00 Lunch
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
AFTERNOON SESSIONS - Scientific Presentations
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
12:30 Registration (check-in/badge pick-up)
13:30 Opening Remarks
13:35 Scientific Presentations | Session 1
15:35 Afternoon Break
16:05 Scientific Presentations | Session 2
18:05 Closing Remarks
18:10 Social Reception
> ORGANIZERS<
Henrik Möbitz, Novartis
Rainer Wilcken, Flare Therapeutics
Steve Maginn, Chemical Computing Group
Markus Kossner, Chemical Computing Group
#MedChem #DrugDiscovery #DrugDesign
--
3moThank you for the great collaboration!